News
World leader in the development and manufacturing of nasal and pulmonary drug delivery devices, Aptar Pharma will unveil its latest innovation, DF30Plus, at the Drug Delivery to the Lungs (DDL) scientific conference, to be held in Edinburgh, Scotland, from December 7th to December 9th, 2011. This new DF30Plus metering valve is the result of continuous improvement to the already world leading DF30 technology platform. Aptar Pharma, a worldwide leader in innovative and proven inhalation drug delivery devices for Asthma and COPD Aptar Pharma is the worldwide leader in aerosol metering valves for pMDIs for the treatment of Asthma and COPD. Aptar Pharma’s metering valves have been selected by major branded pharmaceutical companies and generic producers across the globe. Each year, several hundred million metering valves are produced in Aptar Pharma GMP ISO7 clean rooms. And Aptar Pharma is the only metering valve supplier that designs, develops and manufactures its own elastomer formulations and rubber gaskets – a key component of the valve - within its unique in-house Elastomer Center. DF30Plus, ultra-clean, robust and versatile Aptar Pharma’s DF30 metering valve technology platform has been the industry gold standard for more than 20 years and we are constantly striving to optimize it. The new optimized DF30Plus offers several key benefits: - Better compatibility across a wider range of drug formulations, including ethanol-containing formulations - Designed for cost-effective - Ultra low extractible level - Robust design enables accurate and consistent performance - Excellent pressure filling capability “At Aptar Pharma, we are extremely pleased to announce the launch of this new optimized metering valve. DF30Plus is the result of innovation and continuous improvement to the DF30 technology platform range and provides several new benefits. After 20 years of leading the industry in the supply of metering valves for pMDIs, we still continue to improve our high quality devices and anticipate our customers’ future needs and expectations.” said Chris Baron, Associate Director, Business Development for Aptar Pharma Prescription Division.
Aptar Pharma is part of the Aptargroup family of companies, along with Aptar Beauty + Home and Aptar Food + Beverage. We create innovative drug delivery systems that meet the evolving needs of biotechnology, healthcare and pharmaceutical companies around the world. We provide our customers with a wide range of delivery technologies and analytical services backed by years of proven expertise. Aptargroup (NYSE: ATR) is headquartered in the US and has manufacturing sites in North America, Europe, Asia and South America. For more information, visit www.aptar.com/pharma
Elisa Eschylle, Events and Press relations manager Tel.: + 33 (0)1 39 17 20 41 Email : elisa.eschylle@aptar.com Marion Baschet Vernet Tel.: +44 (0)797 609 4100 Email : mbvernet@gmail.com
Download the press release in PDF format < Back